BeStock  
Stocks › Biotechnology › DSGN

Design Therapeutics DSGN

US equityMarket cap rank #3474Biotechnology
$11.69 −$0.28 (-2.34%)
Pre-market · Oct 8, 7:30 am ET · After hours $11.69 0.00%
Open$11.82
Prev close$11.97
Day range$11.58 – $12.06
Volume344.5K
Market cap$731.58M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$22.67+93.9% vs. price
  • Buy 100%
Low $20.00Now $11.69Avg $22.67High $26.00

Recent rating changes

The last 18 actions on file set price targets from $13.00 to $26.00, averaging $18.28.

DateFirmRatingTarget
2 Oct 2026 Wells Fargo BUY $26.00
4 Aug 2026 Craig-Hallum BUY $22.00
3 Aug 2026 RBC Capital BUY $20.00
15 Jun 2026 Oppenheimer BUY $21.00
27 May 2026 Piper Sandler BUY $20.00
19 May 2026 Craig-Hallum BUY $22.00
18 May 2026 RBC Capital BUY $20.00
4 May 2026 Oppenheimer BUY $21.00
29 Apr 2026 Craig-Hallum BUY $15.00
29 Apr 2026 Piper Sandler BUY $20.00
28 Apr 2026 RBC Capital BUY $14.00
15 Mar 2026 Jefferies BUY $15.00
10 Mar 2026 Craig-Hallum BUY $15.00
10 Mar 2026 Oppenheimer BUY $18.00
7 Jan 2026 Oppenheimer BUY $18.00
3 Dec 2025 Craig-Hallum BUY $15.00
3 Dec 2025 Leerink Partners BUY $14.00
20 Nov 2025 RBC Capital BUY $13.00

Discussion

No comments yet — be the first to weigh in on DSGN.

Leave a comment

Scroll to Top